Zobrazeno 1 - 10
of 297
pro vyhledávání: '"Cassian, Yee"'
Publikováno v:
Advanced Sensor Research, Vol 3, Iss 9, Pp n/a-n/a (2024)
Abstract The detection and quantification of protein biomarkers in bodily fluids is important for many clinical applications, including disease diagnosis and health monitoring. Current techniques for ultrasensitive protein detection, such as enzyme
Externí odkaz:
https://doaj.org/article/892044301e424468a3467f93ae69011b
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 11, Pp 1577-1590 (2023)
Abstract Autologous Chimeric antigen receptor (CAR‐T) cell therapy has been highly successful in the treatment of aggressive hematological malignancies and is also being evaluated for the treatment of solid tumors as well as other therapeutic areas
Externí odkaz:
https://doaj.org/article/f43babcbc5b1492bb69bb0f82fcc856c
Autor:
Susan Peterson, Maria E Suarez-Almazor, Sanjay Shete, Sapna Patel, Cassian Yee, Adi Diab, Padmanee Sharma, Suhendan Ekmekcioglu, Rodabe Amaria, Isabella Glitza, Noha Abdel-Wahab, Michael K Wong, Jennifer McQuade, Michael A Davies, Salah-Eddine Bentebibel, Reham Abdel-Wahab, Hussain Tawbi, Bilal Anouti, Zaida Gonzales, Christine A Spillson, George P Baum, Joanna-Grace M Manzano, David Tweardy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5d00ee8b15a04be3bc16254b7e5f4d6d
Autor:
Jani Huuhtanen, Liang Chen, Emmi Jokinen, Henna Kasanen, Tapio Lönnberg, Anna Kreutzman, Katriina Peltola, Micaela Hernberg, Chunlin Wang, Cassian Yee, Harri Lähdesmäki, Mark M. Davis, Satu Mustjoki
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Previous studies have characterized the diversity and dynamics of the T cell receptor (TCR) repertoire in patients with solid cancer. Here, by analyzing TCR repertoire data from multiple datasets, the authors report that melanoma-associated antigen-s
Externí odkaz:
https://doaj.org/article/768266209ecd42159605fd10e39aeab5
Autor:
Cassian Yee, Anna M Mc Laughlin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/1c41b1330c2f4c879816c0e49fbb5363
Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes
Autor:
Hyo-Jung Lee, Kwon-Ho Song, Se Jin Oh, Suyeon Kim, Eunho Cho, Jungwon Kim, Yun gyu Park, Kyung-Mi Lee, Cassian Yee, Seung-Hwa Song, Suhwan Chang, Jungmin Choi, Sang Taek Jung, Tae Woo Kim
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Translationally controlled tumor protein (TCTP) regulates several cellular processes, including apoptosis, and is overexpressed in several cancer types. Here, the authors report that high levels of TCTP are associated with poor response to anti-PD-L1
Externí odkaz:
https://doaj.org/article/2e832e4f516d4e8ba956b812b9171d28
Autor:
Shailbala Singh, Leticia C. Clemente, Edwin R. Parra, Amanda Tchakarov, Chao Yang, Yisheng Li, James P. Long, Cassian Yee, Jamie S. Lin
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Acute kidney injury (AKI) occurs in ~20% of patients receiving immune checkpoint inhibitor (ICI) therapy; however, only 2–5% will develop ICI-mediated immune nephritis. Conventional tests are nonspecific in diagnosing disease pathology and invasive
Externí odkaz:
https://doaj.org/article/e3961439724d4a29a218e7146b8e9728
Autor:
Daniel B. Zamler, Takashi Shingu, Laura M. Kahn, Kristin Huntoon, Cynthia Kassab, Martina Ott, Katarzyna Tomczak, Jintan Liu, Yating Li, Ivy Lai, Rocio Zorilla-Veloz, Cassian Yee, Kunal Rai, Betty Y.S. Kim, Stephanie S. Watowich, Amy B. Heimberger, Giulio F. Draetta, Jian Hu
Publikováno v:
JCI Insight, Vol 7, Iss 12 (2022)
Novel therapeutic strategies targeting glioblastoma (GBM) often fail in the clinic, partly because preclinical models in which hypotheses are being tested do not recapitulate human disease. To address this challenge, we took advantage of our previous
Externí odkaz:
https://doaj.org/article/f2d1aec989ba484691463ec5f1531b0b
Autor:
Sherille D. Bradley, Amjad H. Talukder, Ivy Lai, Rebecca Davis, Hector Alvarez, Herve Tiriac, Minying Zhang, Yulun Chiu, Brenda Melendez, Kyle R. Jackson, Arjun Katailiha, Heather M. Sonnemann, Fenge Li, Yaan Kang, Na Qiao, Bih-Fang Pan, Philip L. Lorenzi, Mark Hurd, Elizabeth A. Mittendorf, Christine B. Peterson, Milind Javle, Christopher Bristow, Michael Kim, David A. Tuveson, David Hawke, Scott Kopetz, Robert A. Wolff, Patrick Hwu, Anirban Maitra, Jason Roszik, Cassian Yee, Gregory Lizée
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Cytotoxic T lymphocyte (CTL)-based immunotherapies can induce tumor regressions by targeting HLA class I-bound tumor-associated peptides. Here, the authors identified a peptide derived from Vestigial-like 1 (VGLL1) as a shared, potentially therapeuti
Externí odkaz:
https://doaj.org/article/edce20ec2f5b48fd83a56ffb4325c6fb
Autor:
Akash Mitra, Miles C. Andrews, Whijae Roh, Marianna Petaccia De Macedo, Courtney W. Hudgens, Fernando Carapeto, Shailbala Singh, Alexandre Reuben, Feng Wang, Xizeng Mao, Xingzhi Song, Khalida Wani, Samantha Tippen, Kwok-Shing Ng, Aislyn Schalck, Donald A. Sakellariou-Thompson, Eveline Chen, Sangeetha M. Reddy, Christine N. Spencer, Diana Wiesnoski, Latasha D. Little, Curtis Gumbs, Zachary A. Cooper, Elizabeth M. Burton, Patrick Hwu, Michael A. Davies, Jianhua Zhang, Chantale Bernatchez, Nicholas Navin, Padmanee Sharma, James P. Allison, Jennifer A. Wargo, Cassian Yee, Michael T. Tetzlaff, Wen-Jen Hwu, Alexander J. Lazar, P. Andrew Futreal
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-18 (2020)
Immunotherapies now dominate the treatment landscape for melanoma, but why they only work in a subset of patients remains unclear. Here, the authors perform an immunogenomic analysis on 67 intratumor sub-regions of a PD-1 inhibitor resistant melanoma
Externí odkaz:
https://doaj.org/article/97e9b4c4c8f048e9a752f694b5bd17ef